Advances in neuroprotective strategies: Potential therapies for intracerebral hemorrhage

Cerebrovascular Diseases

Volumn 31, Issue 3, 2011, Pages 211-222

  Hwang, Brian Y ^a   Appelboom, Geoffrey ^a   Ayer, Amit ^a   Kellner, Christopher P ^a   Kotchetkov, Ivan S ^a   Gigante, Paul R ^a   Haque, Raqeeb ^a   Kellner, Michael ^a   Connolly, E Sander ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Intracerebral hemorrhage; Neuroprotection; Pathophysiology; Secondary cerebral injury, mechanism

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); AMPA RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; ARGATROBAN; CELECOXIB; DEFEROXAMINE; DIZOCILPINE; HAPTOGLOBIN; HEME; HEME OXYGENASE 1; HEME OXYGENASE 2; HEMOGLOBIN; HIRUDIN; MEMANTINE; MINOCYCLINE; N (2 NAPHTHALENESULFONYL)GLYCYL(DEXTRO)ALPHA AMINOPHENY ALANYL PIPERIDINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; ORF4 PE; POLOXAMER; STANNSOPORFIN; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SULFORAPHANE; TELMISARTAN; THROMBIN; THROMBIN INHIBITOR; TRANSCRIPTION FACTOR NRF2; TUFTSIN; UNCLASSIFIED DRUG; VALPROIC ACID; XG 102;

APOPTOSIS; ASTROCYTOSIS; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INJURY; CELL ACTIVATION; DNA DAMAGE; DRUG MECHANISM; DRUG MEGADOSE; DRUG TARGETING; ENZYME INHIBITION; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INFLAMMATORY CELL; IRON OVERLOAD; MICROGLIA; MOLECULAR PATHOLOGY; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CEREBRAL HEMORRHAGE; EDEMA; ENCEPHALITIS; HUMANS; NEUROPROTECTIVE AGENTS; SIGNAL TRANSDUCTION; STROKE; TREATMENT OUTCOME;

EID: 78650242629     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321870     Document Type: Review

References (124)

1. Kase CS: Intracerebral haemorrhage. Baillieres Clin Neurol 1995; 4: 247-278.
2. Anderson CS: Medical management of acute intracerebral hemorrhage: Curr Opin Crit Care 2009; 15: 93-98.
3. Chuang Y-C, Chen Y-M, Peng S-K, Peng S-Y: Risk stratification for predicting 30-day mortality of intracerebral hemorrhage. Int J Qual Health Care 2009; 21: 441-447.
4. Qureshi AI, Mendelow AD, Hanley DF: Intracerebral haemorrhage. Lancet 2009; 373: 1632-1644.
5. Ducruet AF, Zacharia BE, Hickman ZL, Grobelny BT, Yeh ML, Sosunov SA Jr: ESC: the complement cascade as a therapeutic target in intracerebral hemorrhage. Exp Neurol 2009; 219: 398-403.
6. Lapchak PA, Araujo DM: Advances in hemorrhagic (Pubitemid 47518375)
7. Selim M: Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials. Stroke 2009; 40:S90-S91.
8. Xi G, Keep RF, Hoff JT: Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 2006; 5: 53-63. (Pubitemid 41790696)
9. Lee KR, Kawai N, Kim S, Sagher O, Hoff JT: Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg 1997; 86: 272-278. (Pubitemid 27130687)
10. Hurtado O, Pradillo JM, Alonso-Escolano D, Lorenzo P, Sobrino T, Castillo J, Lizasoain I, Moro MA: Neurorepair versus neuroprotection in stroke. Cerebrovasc Dis 2006; 21 (suppl 2):54-63.
11. Ardizzone TD, Zhan X, Ander BP, Sharp FR: Src kinase inhibition improves acute outcomes after experimental intracerebral hemorrhage. Stroke 2007; 38: 1621-1625. (Pubitemid 46684183)
12. Mayer SA, Rincon F: Treatment of intracerebral haemorrhage. Lancet Neurol 2005; 4: 662-672. (Pubitemid 41317301)
13. Cadichon SB, Le Hoang M, Wright DA, Curry DJ, Kang U, Frim DM: Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats. J Neurosurg 2007; 106: 36-40.
14. Sinn DI, Lee ST, Chu K, Jung KH, Kim EH, Kim JM, Park DK, Song EC, Kim BS, Yoon SS, Kim M, Roh JK: Proteasomal inhibition in intracerebral hemorrhage: neuroprotective and anti-inflammatory effects of bortezomib. Neurosci Res 2007; 58: 12-18. (Pubitemid 46695794)
15. Seyfried D, Han Y, Lu D, Chen J, Bydon A, Chopp M: Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J Neurosurg 2004; 101: 104-107. (Pubitemid 38808468)
16. Sinn D-I, Lee S-T, Chu K, Jung K-H, Song E-C, Kim J-M, Park D-K, Kim M, Roh J-K: Combined neuroprotective effects of celecoxib and memantine in experimental intracerebral hemorrhage. Neurosci Lett 2007; 411: 238-242. (Pubitemid 44828283)
17. Keep RF, Xi G, Hua Y, Hoff JT: The deleterious or beneficial effects of different agents in intracerebral hemorrhage: think big, think small, or is hematoma size important? Stroke 2005; 36: 1594-1596. (Pubitemid 40967538)
18. Gebel JM, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, Spilker J, Tomsick TA, Duldner J, Broderick JP: Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 2002; 33: 2636-2641. (Pubitemid 35266435)
19. Yagi K, Kitazato KT, Uno M, Tada Y, Kinouchi T, Shimada K, Nagahiro S: Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator. Stroke 2009; 40: 626-631.
20. Wang J, Tsirka SE: Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain 2005; 128: 1622-1633. (Pubitemid 41373681)
21. Yenari MA, Xu L, Tang XN, Qiao Y, Giffard RG: Microglia potentiate damage to bloodbrain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 2006; 37: 1087-1093.
22. Wang Q, Tang XN, Yenari MA: The inflammatory response in stroke. J Neuroimmunol 2007; 184: 53-68. (Pubitemid 46365991)
23. Skidmore C, Andrefsky J: Spontaneous intracerebral hemorrhage: epidemiology, pathophysiology, and medical management. Neurosurg Clin North Am 2002; 13: 281-288.
24. Thiex R, Tsirka SE: Brain edema after intracerebral hemorrhage: mechanisms, treatment options, management strategies, and operative indications. Neurosurg Focus 2007; 22:E6.
25. Tomita H, Ito U, Ohno K, Hirakawa K: Chronological changes in brain edema induced by experimental intracerebral hematoma in cats. Acta Neurochir Suppl (Wien) 1994; 60: 558-560.
26. Sansing LH, Kaznatcheeva EA, Perkins CJ, Komaroff E, Gutman FB, Newman GC: Edema after intracerebral hemorrhage: correlations with coagulation parameters and treatment. J Neurosurg 2003; 98: 985-992. (Pubitemid 36460889)
27. Arima H, Wang JG, Huang Y, Heeley E, Skulina C, Parsons MW, Peng B, Li Q, Su S, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Morgenstern LB, Chalmers J, Anderson CS: Significance of perihematomal edema in acute intracerebral hemorrhage: the interact trial. Neurology 2009; 73: 1963-1968.
28. Qing WG, Dong YQ, Ping TQ, Lai LG, Fang LD, Min HW, Xia L, Heng PY: Brain edema after intracerebral hemorrhage in rats: the role of iron overload and aquaporin 4. J Neurosurg 2009; 110: 462-468.
29. Xue M, Yong VW: Matrix metalloproteinases in intracerebral hemorrhage. Neurol Res 2008; 30: 775-782.
30. Wang J, Doré S: Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 2007; 27: 894-908. (Pubitemid 46659028)
31. Sharp F, Liu DZ, Zhan X, Ander BP: Intracerebral hemorrhage injury mechanisms: glutamate neurotoxicity, thrombin, and Src. Acta Neurochir Suppl 2008; 105: 43-46.
32. Aronowski J, Hall CE: New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies. Neurol Res 2005; 27: 268-279. (Pubitemid 40523798)
33. Wasserman JK, Yang H, Schlichter LC: Glial responses, neuron death and lesion resolution after intracerebral hemorrhage in young vs. aged rats. Eur J Neurosci 2008; 28: 1316-1328.
34. Arumugam T, Woodruff T, Lathia J, Selvaraj P, Mattson M, Taylor S: Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience 2009; 158: 1074-1089.
35. Rahpeymai Y, Hietala MA, Wilhelmsson U, Fotheringham A, Davies I, Nilsson AK, Zwirner J, Wetsel RA, Gerard C, Pekny M, Pekna M: Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J 2006; 25: 1364-1374.
36. Hua Y, Keep RF, Hoff JT, Xi G: Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke 2007; 38: 759-762. (Pubitemid 46184254)
37. Hua Y, Keep RF, Hoff JT, Xi G: Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron. J Cereb Blood Flow Metab 2003; 23: 1448-1454. (Pubitemid 38018263)
38. Hua Y, Keep R, Hoff J, Xi G: Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke 2007; 38: 759.
39. Schaden E, Kozek-Langenecker SA: Direct thrombin inhibitors: pharmacology and application in intensive care medicine. Intensive Care Med 2010; 36: 1127-1137.
40. Kitaoka T, Hua Y, Xi G, Hoff JT, Keep RF: Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage. Stroke 2002; 33: 3012-3018. (Pubitemid 35462880)
41. Wu G, Xi G, Huang F: Spontaneous intracerebral hemorrhage in humans: hematoma enlargement, clot lysis, and brain edema. Acta Neurochir Suppl 2006; 96: 78-80.
42. Xi G, Keep RF, Hoff JT: Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg 1998; 89: 991-996. (Pubitemid 28544054)
43. Zhao X, Song S, Sun G, Strong R, Zhang J, Grotta JC, Aronowski J: Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci 2009; 29: 15819-15827.
44. Zhao X, Song S, Sun G, Strong R, Zhang J, Grotta JC, Aronowski J: Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci 2009; 29: 15819-15827.
45. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G: Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 2003; 34: 2964-2969. (Pubitemid 37517778)
46. Qing WG, Dong YQ, Ping TQ, Lai LG, Fang LD, Min HW, Xia L, Heng PY: Brain edema after intracerebral hemorrhage in rats: the role of iron overload and aquaporin 4. J Neurosurg 2009; 110: 462-468.
47. Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT: Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg 2002; 96: 287-293. (Pubitemid 34230243)
48. Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF: Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 2003; 23: 629-652. (Pubitemid 36713668)
49. Regan RF, Panter SS: Hemoglobin potentiates excitotoxic injury in cortical cell culture. J Neurotrauma 1996; 13: 223-231. (Pubitemid 26142615)
50. Goldstein L, Teng ZP, Zeserson E, Patel M, Regan RF: Hemin induces an iron-dependent, oxidative injury to human neuron-like cells. J Neurosci Res 2003; 73: 113-121. (Pubitemid 36791376)
51. Wang J, Zhuang H, Doré S: Heme oxygenase 2 is neuroprotective against intracerebral hemorrhage. Neurobiol Dis 2006; 22: 473-476. (Pubitemid 43842118)
52. Chang EF, Wong RJ, Vreman HJ, Igarashi T, Galo E, Sharp FR, Stevenson DK, Noble- Haeusslein LJ: Heme oxygenase-2 protects against lipid peroxidation-mediated cell loss and impaired motor recovery after traumatic brain injury. J Neurosci 2003; 23: 3689-3696. (Pubitemid 36958477)
53. Qu Y, Chen J, Benvenisti-Zarom L, Ma X, Regan RF: Effect of targeted deletion of the heme oxygenase-2 gene on hemoglobin toxicity in the striatum. J Cereb Blood Flow Metab 2005; 25: 1466-1475. (Pubitemid 41541957)
54. Wagner KR, Hua Y, de Courten-Myers GM, Broderick JP, Nishimura RN, Lu SY, Dwyer BE: Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies. Cell Mol Biol (Noisy-le-grand) 2000; 46: 597-608.
55. Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G: Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. Neurosurg Focus 2003; 15:ECP4.
56. Okauchi M, Hua Y, Keep RF, Morgenstern LB, Schallert T, Xi G: Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration. Stroke 2010; 41: 375-382.
57. Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA: Nrf2, a multi-organ protector? FASEB J 2005; 19: 1061-1066. (Pubitemid 40946431)
58. Kensler TW, Wakabayashi N, Biswal S: Cell survival responses to environmental stresses via the keap1-nrf2-are pathway. Annu Rev Pharmacol Toxicol 2006; 47: 89-116.
59. Zhao J, Moore AN, Redell JB, Dash PK: Enhancing expression of nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci 2007; 27: 10240-10248. (Pubitemid 47450456)
60. Wang J, Fields J, Zhao C, Langer J, Thimmulappa RK, Kensler TW, Yamamoto M, Biswal S, Doré S: Role of nrf2 in protection against intracerebral hemorrhage injury in mice. Free Radic Biol Med 2007; 43: 408-414. (Pubitemid 46977628)
61. Zhao X, Sun G, Zhang J, Strong R, Dash PK, Kan YW, Grotta JC, Aronowski J: Transcription factor nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke 2007; 38: 3280-3286. (Pubitemid 350175749)
62. Fitzgerald GA, Patrono C: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001; 345: 443-442.
63. Graham SH, Hickey RW: Cyclooxygenases in central nervous system diseases: a special role for cyclooxygenase 2 in neuronal cell death. Arch Neurol 2003; 60: 628-630. (Pubitemid 36427981)
64. Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Almert G, Przedborski S, Rothstein JD: Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2002; 52: 771-778. (Pubitemid 35403187)
65. Iadecola C: Cyclooxygenase-2 and stroke: the long and the short of it. Ann Neurol 2003; 54: 141-142.
66. Bryzgina TM, Aleksiuk LI, Martynova TV, Sukhina VS, Aleksieieva IM: Effect of inhibitors of cyclooxygenase and lipoxygenase pathways of arachidonic acid oxidation on the immune response and the activity of the monoxygenase system and lipid peroxidation in the spleen and liver in mice. Fiziol Zh 2001; 47: 46-52.
67. Chu K, Jeong S-W, Jung K-H, Han S-Y, Lee S-T, Kim M, Roh J-K: Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death. J Cereb Blood Flow Metab 2004; 24: 926-933. (Pubitemid 39045410)
68. Rosenberg GA: Matrix metalloproteinases in neuroinflammation. Glia 2002; 39: 279-291.
69. Yong VW, Power C, Forsyth P, Edwards DR: Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001; 2: 502-511. (Pubitemid 33676585)
70. Giancotti F, Ruoslahti E: Integrin signaling. Science 1999; 285: 1028-1032.
71. Sinn D-I, Chu K, Lee S-T, Song E-C, Jung K-H, Kim E-H, Park D-K, Kang K-M, Kim M, Roh J-K: Pharmacological induction of heat shock protein exerts neuroprotective effects in experimental intracerebral hemorrhage. Brain Res 2007; 1135: 167-176. (Pubitemid 46188430)
72. Chen-Roetling J, Chen L, Regan RF: Minocycline attenuates iron neurotoxicity in cortical cell cultures. Biochem Biophys Res Commun 2009; 386: 322-326.
73. Morioka T, Kalehua AN, Streit WJ: Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J Comp Neurol 1993; 327: 123-132. (Pubitemid 23006616)
74. Wang J, Tsirka SE: Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke 2005; 36: 613-618. (Pubitemid 40344165)
75. Garrett MC, Otten ML, Starke RM, Komotar RJ, Magotti P, Lambris JD, Rynkowski MA, Connolly ES: Synergistic neuroprotective effects of c3a and c5a receptor blockade following intracerebral hemorrhage. Brain Res 2009; 1298: 171-177.
76. Titova E, Ostrowski RP, Kevil CG, Tong W, Rojas H, Sowers LC, Zhang JH, Tang J: Reduced brain injury in cd18-deficient mice after experimental intracerebral hemorrhage. J Neurosci Res 2008; 86: 3240-3245.
77. Revan S, Montesinos MC, Naime D, Landau S, Cronstein BN: Adenosine a2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase. J Biol Chem 1996; 271: 17114-17118. (Pubitemid 26244260)
78. Mayne M, Fotheringham J, Yan HJ, Power C, Del Bigio MR, Peeling J, Geiger JD: Adenosine a2a receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Ann Neurol 2001; 49: 727-735. (Pubitemid 32530239)
79. Schütze S, Wiegmann K, Machleidt T, Krönke M: TNF-induced activation of NF-κ b. Immunobiology 1995; 193: 193-203.
80. Mathiesen T, Edner G, Ulfarsson E, Andersson B: Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-α following subarachnoid hemorrhage. J Neurosurg 1997; 87: 215-220. (Pubitemid 27349105)
81. Lin C-L, Dumont AS, Tsai Y-J, Huang J-H, Chang KP, Kwan AL, Hong YR, Howng SL: 17-estradiol activates adenosine a2a receptor after subarachnoid hemorrhage. J Surg Res 2009; 157: 208-215.
82. Mayne M, Ni W, Yan HJ, Xue M, Johnston JB, Del Bigio MR, Peeling J, Power C: Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-α expression is neuroprotective after intracerebral hemorrhage. Stroke 2001; 32: 240-248. (Pubitemid 32063851)
83. Walther T, Olah L, Harms C, Maul B, Bader M, Hörtnagl H, Schultheiss H-P, Mies G: Ischemic injury in experimental stroke depends on angiotensin II. FASEB J 2002; 16: 169-176. (Pubitemid 34113010)
84. Agnoletti L, Curello S, Bachetti T, Malacarne F, Gaia G, Comini L, Volterrani M, Bonetti P, Parrinello G, Cadei M, Grigolato PG, Ferrari R: Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-α . Circulation 1999; 100: 1983-1991. (Pubitemid 29529291)
85. Endres M, Laufs U, Liao JK, Moskowitz MA: Targeting eNOS for stroke protection. Trends Neurosci 2004;27: 283-289. (Pubitemid 38529957)
86. Iadecola C: Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997; 20: 132-139. (Pubitemid 27086729)
87. Jung K-H, Chu K, Lee S-T, Kim S-J, Song E-C, Kim E-H, Park D-K, Sinn D-I, Kim J-M, Kim M, Roh J-K: Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage. J Pharmacol Exp Ther 2007; 322: 1051-1058. (Pubitemid 47295814)
88. Zhao CY, Wang JB, Deng ZJ, Liu JW, Li JM, Li L, Jiang LL: Relationship between NF-κ b binding activity and expression of PPAR γ - mRNA in the livers of rats with fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 2005; 13: 96-100.
89. Kawakami M, Sekiguchi M, Sato K, Kozaki S, Takahashi M: Erythropoietin receptormediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol Chem 2001; 276: 39469-39475.
90. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery MA, Kurtz TW: Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR γ -modulating activity. Hypertension 2004; 43: 993-1002. (Pubitemid 38579904)
91. Creson TK, Yuan P, Manji HK, Chen G: Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate. J Mol Neurosci 2009; 37: 123-134.
92. Pan T, Li X, Xie W, Jankovic J, Le W: Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells. FEBS Lett 2005; 579: 6716-6720. (Pubitemid 41773675)
93. Pandey P, Farber R, Nakazawa A, Kumar S, Bharti A, Nalin C, Weichselbaum R, Kufe D, Kharbanda S: Hsp27 functions as a negative regulator of cytochrome C-dependent activation of procaspase-3. Oncogene 2000; 19: 1975-1981. (Pubitemid 30229410)
94. Hashimoto R, Hough C, Nakazawa T, Yamamoto T, Chuang D-M: Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J Neurochem 2002; 80: 589-597. (Pubitemid 34809967)
95. Sinn D-I, Kim S-J, Chu K, Jung K-H, Lee S-T, Song E-C, Kim J-M, Park D-K, Kun Lee S, Kim M, Roh J-K: Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. Neurobiol Dis 2007; 26: 464-472. (Pubitemid 46578295)
96. Wiegler K, Bonny C, Coquoz D, Hirt L: The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator. Cerebrovasc Dis 2008; 26: 360-366.
97. Michel-Monigadon D, Bonny C, Hirt L: c- Jun N-terminal kinase pathway inhibition in intracerebral hemorrhage. Cerebrovasc Dis 2010; 29: 564-570.
98. Palin K, McCusker RH, Strle K, Moos F, Dantzer R, Kelley KW: Tumor necrosis factor-α -induced sickness behavior is impaired by central administration of an inhibitor of c-Jun N-terminal kinase. Psychopharmacology (Berl) 2008; 197: 629-635.
99. Lipton S, Chen HS: Paradigm shift in neuroprotective drug development: Clinically tolerated nMDA receptor inhibition by memantine. Cell Death Differ 2004; 11: 18-20. (Pubitemid 38111368)
100. Noch E, Khalili K: Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity. Cancer Biol Ther 2009; 8: 1791-1797.
101. Ardizzone TD, Lu A, Wagner KR, Tang Y, Ran R, Sharp FR: Glutamate receptor blockade attenuates glucose hypermetabolism in perihematomal brain after experimental intracerebral hemorrhage in rat. Stroke 2004; 35: 2587-2591. (Pubitemid 39458422)
102. Wang S-J: A role for Src kinase in the regulation of glutamate release from rat cerebrocortical nerve terminals. Neuroreport 2003; 14: 1519-1522. (Pubitemid 37083141)
103. Liu Y, Zhang G, Gao C, Hou X: NMDA receptor activation results in tyrosine phosphorylation of NMDA receptor subunit 2A(NR2A) and interaction of PYK2 and Src with NR2A after transient cerebral ischemia and reperfusion. Brain Res 2001; 909: 51-58. (Pubitemid 32710117)
104. Thiex R, Weis J, Krings T, Barreiro S, Yakisikli- Alemi F, Gilsbach JM, Rohde V: Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages. J Neurosurg 2007; 106: 314-320. (Pubitemid 46203161)
105. Lee S-T, Chu K, Jung K-H, Kim J, Kim E-H, Kim S-J, Sinn D-I, Ko S-Y, Kim M, Roh J-K: Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement. J Cereb Blood Flow Metab 2006; 26: 536-544.
106. Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM: The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 2004; 24: 945-963. (Pubitemid 39223619)
107. Maskarinec SA, Hannig J, Lee RC, Lee KYC: Direct observation of poloxamer 188 insertion into lipid monolayers. Biophys J 2002; 82: 1453-1459. (Pubitemid 34204765)
108. Marks JD, Pan CY, Bushell T, Cromie W, Lee RC: Amphiphilic, tri-block copolymers provide potent membrane-targeted neuroprotection. FASEB J 2001; 15: 1107-1109.
109. Curry DJ, Wright DA, Lee RC, Kang UJ, Frim DM: Poloxamer 188 volumetrically decreases neuronal loss in the rat in a timedependent manner. Neurosurgery 2004; 55: 943-948; discussion 948-949.
110. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A: Erythropoietin crosses the bloodbrain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000; 97: 10526-10531.
111. Sasaki R: Pleiotropic functions of erythropoietin. Intern Med 2003; 42: 142-149. (Pubitemid 36372351)
112. Lee S-T, Chu K, Sinn D-I, Jung K-H, Kim E-H, Kim S-J, Kim J-M, Ko S-Y, Kim M, Roh J-K: Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. J Neurochem 2006; 96: 1728-1739 (Pubitemid 43351630)
113. Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, Genc S, Genc K, Sagiroglu E, Cerami A, Brines M: Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 2002; 99: 2258-2263. (Pubitemid 34169048)
114. Grasso G, Graziano F, Sfacteria A, Carletti F, Meli F, Maugeri R, Passalacqua M, Certo F, Fazio M, Buemi M, Iacopino DG: Neuroprotective effect of erythropoietin and darbepoetin- after experimental intracerebral hemorrhage. Neurosurgery 2009; 65: 763-769; discussion 769-770.
115. Lu A, Tang Y, Ran R, Ardizzone TL, Wagner KR, Sharp FR: Brain genomics of intracerebral hemorrhage. J Cereb Blood Flow Metab 2006; 26: 230-252. (Pubitemid 43151579)
116. Gong Y, Hua Y, Keep RF, Hoff JT, Xi G: Intracerebral hemorrhage: effects of aging on brain edema and neurological deficits. Stroke 2004; 35: 2571-2575. (Pubitemid 39458419)
117. Thiex R, Mayfrank L, Rohde V, Gilsbach JM, Tsirka SA: The role of endogenous versus exogenous TPA on edema formation in murine ICH. Exp Neurol 2004; 189: 25-32. (Pubitemid 39024452)
118. Arima H, Wang JG, Huang Y, Heeley E, Skulina C, Parsons MW, Peng B, Li Q, Su S, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Morgenstern LB, Chalmers J, Anderson CS, Investigators I: Significance of perihematomal edema in acute intracerebral hemorrhage: the interact trial. Neurology 2009; 73: 1963-1968.
119. Gebel JM, Brott TG, Sila CA, Tomsick TA, Jauch E, Salisbury S, Khoury J, Miller R, Pancioli A, Duldner JE, Topol EJ, Broderick JP: Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage. Stroke 2000; 31: 596-600. (Pubitemid 30131642)
120. Gebel JM Jr, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, Spilker J, Tomsick TA, Duldner J, Broderick JP: Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 2002; 33: 2631-2635. (Pubitemid 35266434)
121. Xue M, Hollenberg MD, Yong VW: Combination of thrombin and matrix metalloproteinase- 9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice. J Neurosci 2006; 26: 10281-10291. (Pubitemid 44527421)
122. MacLellan CL, Silasi G, Poon CC, Edmundson CL, Buist R, Peeling J, Colbourne F: Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab 2008; 28: 516-525. (Pubitemid 351304262)
123. Bullock R, Brock-Utne J, van Dellen J, Blake G: Intracerebral hemorrhage in a primate model: effect on regional cerebral blood flow. Surg Neurol 1988; 29: 101-107. (Pubitemid 18041629)
124. Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M: Collagenase-induced intracerebral hemorrhage in rats. Stroke 1990; 21: 801-807. (Pubitemid 20180807)